273 related articles for article (PubMed ID: 31636528)
1. Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients.
Bai Z; Chen D; Wang L; Zhao Y; Liu T; Yu Y; Yan T; Cheng Y
Front Neurosci; 2019; 13():1026. PubMed ID: 31636528
[No Abstract] [Full Text] [Related]
2. Central Inflammatory Cytokines in Tuberculous Meningitis: A Systematic Review and Meta-analysis.
Saghazadeh A; Rezaei N
J Interferon Cytokine Res; 2022 Mar; 42(3):95-107. PubMed ID: 35298290
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.
Agah E; Zardoui A; Saghazadeh A; Ahmadi M; Tafakhori A; Rezaei N
PLoS One; 2018; 13(1):e0190252. PubMed ID: 29346446
[TBL] [Abstract][Full Text] [Related]
4. A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis.
Sun M; Liu N; Xie Q; Li X; Sun J; Wang H; Wang M
Mult Scler Relat Disord; 2021 Jun; 51():102870. PubMed ID: 33819724
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
Olesen MN; Soelberg K; Debrabant B; Nilsson AC; Lillevang ST; Grauslund J; Brandslund I; Madsen JS; Paul F; Smith TJ; Jarius S; Asgari N
J Neuroinflammation; 2019 Mar; 16(1):59. PubMed ID: 30857557
[TBL] [Abstract][Full Text] [Related]
6. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Olsson B; Lautner R; Andreasson U; Öhrfelt A; Portelius E; Bjerke M; Hölttä M; Rosén C; Olsson C; Strobel G; Wu E; Dakin K; Petzold M; Blennow K; Zetterberg H
Lancet Neurol; 2016 Jun; 15(7):673-684. PubMed ID: 27068280
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
Chen X; Hu Y; Cao Z; Liu Q; Cheng Y
Front Immunol; 2018; 9():2122. PubMed ID: 30283455
[TBL] [Abstract][Full Text] [Related]
8. Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis.
Ma Y; Wang J; Guo S; Meng Z; Ren Y; Xie Y; Wang M
Front Immunol; 2022; 13():1064007. PubMed ID: 36761173
[TBL] [Abstract][Full Text] [Related]
9. Cytokines and chemokines profile in encephalitis patients: A meta-analysis.
Soltani Khaboushan A; Pahlevan-Fallahy MT; Shobeiri P; Teixeira AL; Rezaei N
PLoS One; 2022; 17(9):e0273920. PubMed ID: 36048783
[TBL] [Abstract][Full Text] [Related]
10. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
[TBL] [Abstract][Full Text] [Related]
11. Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis.
Kothur K; Wienholt L; Mohammad SS; Tantsis EM; Pillai S; Britton PN; Jones CA; Angiti RR; Barnes EH; Schlub T; Bandodkar S; Brilot F; Dale RC
PLoS One; 2016; 11(8):e0161656. PubMed ID: 27575749
[TBL] [Abstract][Full Text] [Related]
12. Comparison of multiplex platforms for cytokine assessments and their potential use for biomarker profiling in multiple sclerosis.
Malekzadeh A; Twaalfhoven H; Wijnstok NJ; Killestein J; Blankenstein MA; Teunissen CE
Cytokine; 2017 Mar; 91():145-152. PubMed ID: 28082233
[TBL] [Abstract][Full Text] [Related]
13. Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases.
Lepennetier G; Hracsko Z; Unger M; Van Griensven M; Grummel V; Krumbholz M; Berthele A; Hemmer B; Kowarik MC
J Neuroinflammation; 2019 Nov; 16(1):219. PubMed ID: 31727097
[TBL] [Abstract][Full Text] [Related]
14. Paediatric onset of multiple sclerosis: Analysis of chemokine and cytokine levels in the context of the early clinical course.
Nohejlova H; Kayserova J; Capek V; Toman T; Krsek P; Liba Z
Mult Scler Relat Disord; 2020 Nov; 46():102467. PubMed ID: 32889374
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.
Ozenci V; Kouwenhoven M; Huang YM; Kivisäkk P; Link H
Clin Exp Immunol; 2000 Apr; 120(1):147-53. PubMed ID: 10759776
[TBL] [Abstract][Full Text] [Related]
16. B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.
Kothur K; Wienholt L; Tantsis EM; Earl J; Bandodkar S; Prelog K; Tea F; Ramanathan S; Brilot F; Dale RC
PLoS One; 2016; 11(2):e0149411. PubMed ID: 26919719
[TBL] [Abstract][Full Text] [Related]
17. Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid.
Mellergård J; Edström M; Vrethem M; Ernerudh J; Dahle C
Mult Scler; 2010 Feb; 16(2):208-17. PubMed ID: 20007431
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
19. Role of Chitinase 3-like 1 as a Biomarker in Multiple Sclerosis: A Systematic Review and Meta-analysis.
Floro S; Carandini T; Pietroboni AM; De Riz MA; Scarpini E; Galimberti D
Neurol Neuroimmunol Neuroinflamm; 2022 Jul; 9(4):. PubMed ID: 35534236
[TBL] [Abstract][Full Text] [Related]
20. IL-6 and TNF-α responses to acute and regular exercise in adult individuals with multiple sclerosis (MS): a systematic review and meta-analysis.
Shobeiri P; Seyedmirzaei H; Karimi N; Rashidi F; Teixeira AL; Brand S; Sadeghi-Bahmani D; Rezaei N
Eur J Med Res; 2022 Sep; 27(1):185. PubMed ID: 36156182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
